Industry News
Vetter Implements New Serialization Services
Vetter launches new serialization process to support track-and-trace efforts.
Regulatory Compliance Associates Expands into Poland
RCA opens a new office in Warsaw, Poland.
XstalBio Launches Vaccine Analysis Service
XstalBio Analytics' approach to vaccine analysis and formulation is aimed at understanding the antigen– adjuvant interaction.
FDA approves Novartis' Xolair for Rare Skin Disease
FDA approves Xolair (omalizumab) for the treatment of a rare skin disease known as chronic idiopathic urticarial.
Texas A&M Center Adds Mobile Cleanrooms
Walker Barrier Systems builds eight mobile clean rooms for the Texas A&M Center for Innovation in Advanced Development and Manufacturing.
DPx Launched as Provider of Pharmaceutical Services, Fine Chemicals, and Proprietary Technologies
$2.6 billion transaction combines Patheon and DSM Pharmaceutical to create CDMO, DPx.
Almac Expands Asia Pacific Operations
Almac expands technical, project, and operational resources in Asia.
Johnson Controls Launches Integrated Laboratory Services
Johnson Controls launches Integrated Laboratory Services for R&D facility operations and scientific productivity.
CPhI Report Shows R&D Market Diversifying
CPhI report shows R&D market diversifying with increased partnerships, mergers, and revenue sharing models.
Cobra Biologics and BioCancell Collaborate on Cancer Therapy Drug
Cobra Biologics and BioCancell announce an agreement to manufacture BioCancell's BC-821 cancer drug.
Waters Marks Ten Years of ACQUITY UPLC With the Introduction of New Products
Waters celebrates ten&$45;year anniversary of the ACQUITY UPLC System.
FDA Approves Orphan Drug Myalept
FDA approves the orphan drug Myalept for the treatment of leptin deficiency.
UC Santa Barbara Students Get Bexsero to Treat Meningitis B
Novartis provides its second US university with Bexsero for the treatment of meningitis B.
Elanco to Acquire Lohmann Animal Health
Elanco acquires Germany-based Lohmann Animal Health.
BDP Week Covers Bioprocessing Methods
Conference sessions, keynote events, exhibits, and poster sessions cover different aspects of bioprocessing.
Ecolab Rebrands Shield Medicare Division
Ecolab's Shield Medicare division will now be called Ecolab Contamination Control.
Agilent Technologies, Cell Line Genetics Collaborate
Agilent Technologies and Cell Line Genetics will collaborate on services for regenerative medicine and cancer research.
Debiopharm Group to Acquire Affinium Antibiotic Clinical Assets
Debiopharm acquires Affinium's clinical and preclinical assets and its technology platform.
GMP Certification Extended for Cobra Biologics
Cobra Biologics' GMP Compliance Certification has been extended to include QC testing.
Shimadzu Opens New Solution Center in Maryland
Shimadzu's new Solution Center features additional research space.
Cytovance Biologics Expands GMP Warehouse and Manufacturing Operations
Cytovance Biologics continues to work on the expansion of a manufacturing operations and GMP warehousing facility in Oklahoma.
Aesica Appoints Commercial Managing Director
Aesica appoints Ian Muir to the newly created position of commercial managing director.
Sartorius Appoints New Head of Lab Products & Services Division
Sartorius appoints Michael Melingo to head marketing, sales, and services of the Lab Products & Services Division.
FDA Outlines Agenda for New Guidances in 2014
FDA plans to issue a number of new guidances in 2014 that will address drug development and manufacturing practices.
Thermo Fisher Scientific Completes Acquisition of Life Technologies
Thermo Fisher Scientific outlines new business segments with acquisition of Life Technologies.
ISPE CEO to Step Down at End of 2014
International Society for Pharmaceutical Engineering will continue strategic plan initiated by Nancy Berg; search begins for replacement.
EMD Millipore Expands its Emprove Raw Materials Portfolio
EMD Millipore's expands its Emprove raw materials portfolio to include 400 products.
PharmaCell to Purchase Cell Therapy Production Facility from TiGenix
PharmaCell enters an agreement purchase TiGenix therapy production facility.
Novozymes Biopharma's Technology Demonstrates Potential for Monthly Drug Dosing
Novozymes Biopharma has released new study data on extending the serum half-life of albumin in vivo.
